GSK Anti-Nausea Drug Zofran Under FDA Review | ThirdAge
Links shared publicly online about this topic.
- 0total visits
GSK Anti-Nausea Drug Zofran Under FDA Review | ThirdAge
GSK (GlaxoSmithKline) anti-nausea cancer drug Zofran is under review by the Food and Drug Administration, the agency reported Thursday.
View full resource at thirdage.com
Tags: Nausea and Vomiting Medication, Cancer, Cancer Medication, Drug, FDA, Zofran, GlaxoSmithKline
Most Recently Shared on September 16, 2011 at 12:15 am By:
GSK Anti-Nausea Drug Zofran Under FDA Review http://t.co/9TgSqcM1
Advertisement
